Central Nervous System Tumors [clinicaltrials_resource:3447c86f15da3c8021b503ed20e9b98f]
clinicaltrials:NCT00002875clinicaltrials:NCT00002944Gene Testing to Help in the Diagnosis and Treatment of Childhood Brain Tumors [clinicaltrials:NCT00003096]clinicaltrials:NCT00003141clinicaltrials:NCT00003203clinicaltrials:NCT00003573clinicaltrials:NCT00003625clinicaltrials:NCT00003935clinicaltrials:NCT00005812clinicaltrials:NCT00040911clinicaltrials:NCT00047320clinicaltrials:NCT00066248clinicaltrials:NCT00100802clinicaltrials:NCT00107471clinicaltrials:NCT00109798Chemotherapy With CD133+ Select Autologous Hematopoietic Stem Cells for Children With Solid Tumors and Lymphomas [clinicaltrials:NCT00152126]clinicaltrials:NCT00187226Clinical Studies of Gemcitabine-Oxaliplatin [clinicaltrials:NCT00407433]clinicaltrials:NCT00477503Administration of High Dose Thiotepa and Melphalan With Autologous Hematopoietic Stem Cell Transplant in Children and Adolescents With Solid Tumors [clinicaltrials:NCT00607984]Study of Irinotecan and Bevacizumab With Temozolomide in Refractory/Relapsed Central Nervous System (CNS) Tumors [clinicaltrials:NCT00876993]DNA Analysis of Tumor Tissue Samples From Patients With Diffuse Brain Stem Glioma [clinicaltrials:NCT00899834]Assessing the Effectiveness of Individual Education Plans for Childhood Cancer Survivors [clinicaltrials:NCT00945828]OXC401-PO1s/WVU 1309 - A Pilot Study of Fosbretabulin With Bevacizumab in Recurrent High-Grade Gliomas [clinicaltrials:NCT01052363]Outcomes Study of Late Effects After Proton RT for Pediatric Tumors of the Brain, Head, and Neck [clinicaltrials:NCT01067196]Study of Vinblastine and Sirolimus in Pediatric Patients With Recurrent or Refractory Solid Tumors Including Central Nervous System Tumors [clinicaltrials:NCT01135563]clinicaltrials:NCT01164189clinicaltrials:NCT01735747Pemetrexed and Temozolomide in Treating Patients With Relapsed Primary Central Nervous System Lymphoma (PCNSL) [clinicaltrials:NCT01985451]clinicaltrials:NCT02303028Study of BLZ-100 in Pediatric Subjects With CNS Tumors [clinicaltrials:NCT02462629]
condition [clinicaltrials_vocabulary:condition]
Central Nervous System Tumors [clinicaltrials_resource:3447c86f15da3c8021b503ed20e9b98f]
Bio2RDF identifier
3447c86f15da3c8021b503ed20e9b98f
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:3447c86f15da3c8021b503ed20e9b98f
identifier
clinicaltrials_resource:3447c86f15da3c8021b503ed20e9b98f
title
Central Nervous System Tumors
@en
label
Central Nervous System Tumors [clinicaltrials_resource:3447c86f15da3c8021b503ed20e9b98f]
@en